drugset / Trial / NCT04651855
The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS
Phase 1/2
Unknown
20 enrolled
Polski Bank Komorek Macierzystych JSC (PBKM)
National Center for Research and Development, Poland · collab
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety of intrathecal administration of Wharton's Jelly Mesenchymal Stem Cells (WJMSC) and the impact on the immune system of patients with Amyotrophic Lateral Sclerosis.
Timeline
- Start
- 2020-12-02
- Primary completion
- 2022-03-08
- Completion
- 2023-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Wharton's Jelly Mesenchymal Stem Cells | Cell therapy | — | Intrathecal |